1. Search Result
Search Result
Results for "

IP6K1/2/3

" in MedChemExpress (MCE) Product Catalog:

5

Inhibitors & Agonists

1

Recombinant Proteins

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-110079

    Others Cancer
    TNP is a cell-permeable inhibitor of IP6K1 and IP3K, with IC50 values of 0.55 µM and 10.2 µM for IP3K, respectively. TNP binds to the ATP-binding sites of both enzymes .
    TNP
  • HY-150607

    Others Others
    UNC7467 is a potent IP6K inhibitor with values of 4.9, 8.9 and 1320 nM for IP6K2, IP6K1 and IP6K6, respectively. UNC7467 reduces levels of inositol pyrophosphates. UNC7467 can be used for obesity research .
    UNC7467
  • HY-RS06861

    Small Interfering RNA (siRNA) Others

    IP6K1 Human Pre-designed siRNA Set A contains three designed siRNAs for IP6K1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    IP6K1 Human Pre-designed siRNA Set A
    IP6K1 Human Pre-designed siRNA Set A
  • HY-122706

    IKK Metabolic Disease
    TBK1/IKKε-IN-3 is a potent IP6K inhibitor with IC50 values of 3, 8.65 and 3.72 μM for IP6K1, IP6K2 and IP6K3, respectively. TBK1/IKKε-IN-3 can be used in the study of obesity diseases. .
    TBK1/IKKε-IN-3
  • HY-153530

    Others Neurological Disease Metabolic Disease
    LI-2242 is an inositol hexakisphosphate kinase (IP6K) inhibitor. LI-2242 has inhibition effect for IP6K1, IP6K2, IP6K3 and IPMK with IC50 values of 31 nM, 42 nM, 8.7 nM and 1944 nM, respectively. LI-2242 can be used for thew research of type II diabetes, obesity, metabolic complications, venous thrombosis, and psychiatric disorders .
    LI-2242

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: